We are pleased to announce the launch of the IDS SHBG assay and the IDS ACE assay, in the European market, for use with the IDS Automated System. The IDS SHBG assay is a new addition to the IDS Fertility portfolio and the IDS ACE assay is the first biochemistry test for the IDS Automated […]
Immunodiagnostic Systems Holdings plc (“IDS”), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, has reached agreement with Technogenetics srl (“TGS”) to enable IDS to sell TGS’s range of assay kits under the IDS brand, on a global basis. TGS is an innovative company that has been active […]
MEDLAB is the largest attended laboratory expo worldwide, now moving onto its 2nd year as a standalone show. The gathering will welcome over 600 exhibitors and will be accompanied by 17 multi-disciplinary CME-accredited conferences. The Congress provides education, best practise and the chance to learn, meet and network with leading laboratorians from across the globe, […]
Immunodiagnostic Systems Holdings PLC are pleased to announce the release of the Annual Report and Accounts for the 2017 financial year. This report and the Annual General Meeting documents are now available for download from the following links: Annual Report and Accounts 2017 Notice of Annual General Meeting 2017
We are pleased to announce the launch of the IDS-iSYS 17-OH Progesterone assay in the European market – a fully automated assay for use with the IDS-iSYS Multi-Discipline Automated System. The launch of the IDS-iSYS 17-OH Progesterone assay is the first product released as part of the upcoming fertility (steroid hormones) portfolio. The IDS-iSYS 17-OH […]
